关于上海证券交易所《关于倍加洁集团股份有限公司 2024 年年度报 告的信息披露监管问询函》之回复 上海证券交易所上市公司管理一部: 贵所于 2025年 6 月 16 日出具的《关于倍加洁集团股份有限公司 2024 年年 度报告的信息披露监管问询函(上证公函[2025]0852 号)》(以下简称"《问询 函》")已收悉。根据《问询函》的相关要求,倍加洁集团股份有限公司(以下 简称"倍加洁集团"、"上市公司"、"公司"）、上海科东资产评估有限公司(以下 简称"评估机构"）对有关问题进行了积极认真的核查、分析和研究,现就《问询 函》相关内容作如下回复说明。 除特别说明,本回复所述的词语或简称与《倍加洁集团股份有限公司 2024 年年度报告》中所定义的词语或简称具有相同的含义。 间题二、关于业绩承诺。年报及前期公告显示,2024年4月7日,公司收 购善恩康生物科技(苏州)有限公司(以下简称善恩康)52.00%股权,标的资产 增值率 656.94%,形成商誉 9101.28 万元。交易对手方承诺善恩康 2024 年-2026 年实现扣非净利润分别不低于 1200万元、1800 万元及 3000万元,三年累计不 低于 ...

立信会计师事务所（特殊普通合伙） 关于倍加洁集团股份有限公司 2024 年年度报告的信息披露监管问询函的回复 信会师函字[2025]第 ZA333 号 上海证券交易所： 根据贵所对出具的《关于倍加洁集团股份有限公司 2024 年年度 报告的信息披露监管问询函》（上证公函【2025】0852 号）（以下 简称"问询函"）的要求，立信会计师事务所（特殊普通合伙）（以下 简称"我们"或"年审会计师"）作为倍加洁集团股份有限公司（以下简 称"公司"或"倍加洁"）2024 年度审计会计师，对问询事项中需要会计 师发表意见的问题进行了认真核查，现回复如下： 注：若无特别说明，本函所使用的简称或名词释义与《倍加洁集 团股份有限公司 2024 年年度报告》一致；回复中若出现合计数与各 分项数值相加之和在尾数上存在差异，均因四舍五入原因所致。 问题 1.关于经营情况 年报显示，公司主营口腔清洁护理用品、一次性卫生用品以及益生菌 制品的研发、生产和销售，报告期内实现营业收入 12.99 亿元，同比增长 21.78%，其中海外业务营收 7.84 亿元，占营业收入比重为 60.35%。公司 海外业务毛利率为 25.44%，较国内高出 ...

销售模式、定价模式及市场行情、同行业可比公司情况，说明国内销售毛利率 与海外毛利率差异原因，报告期相关收入同比变化原因及合理性。请年审会计 师发表意见。 公司回复 证券代码：603059 证券简称：倍加洁 公告编号：2025-034 倍加洁集团股份有限公司 关于 2024 年年度报告信息披露监管问询函的 回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 倍加洁集团股份有限公司（以下简称"公司"或"倍加洁"）于近日收到上 海证券交易所上市公司管理一部下发的《关于倍加洁集团股份有限公司 2024 年 年度报告的信息披露监管问询函》（上证公函【2025】0852 号）（以下简称"《问 询函》"）。根据《问询函》的要求，公司与立信会计师事务所（特殊普通合伙） （以下简称"年审会计师"）、上海科东资产评估有限公司（以下简称"评估机构"） 就《问询函》提及的事项逐项进行了认真核查与落实，现将《问询函》所涉及问 题回复如下： 在《问询函》相关问题的回复中，若合计数与各分项数值相加之和在尾数上 存在差异，均为四舍五入所致。如无特别说明 ...

Core Viewpoint - The company, Beijia Clean (倍加洁), announced a share reduction plan by its shareholders due to funding needs, which may impact the stock's performance in the market [1] Shareholder Reduction Plan - Shareholders Nanjing Xiaobei No.1 and Nanjing Xiaobei No.2 plan to reduce their holdings through block trading, with Xiaobei No.1 intending to sell up to 1,250,000 shares (approximately 1.2444% of total shares) and Xiaobei No.2 up to 750,000 shares (approximately 0.7466% of total shares) [1] - The reduction will occur within three months after the announcement, with a limit of 2% of total shares in any consecutive 90-day period [1] Shareholder Background - The shareholders involved are employee stock ownership platforms, with the actual controller Zhang Wensheng also serving as the executive partner of both Xiaobei No.1 and Xiaobei No.2, indicating a unified action relationship among them [2] - As of the announcement date, Xiaobei No.1 holds 6,875,000 shares (6.8443% of total shares) and Xiaobei No.2 holds 4,125,000 shares (4.1066% of total shares) [1][2] Financial Performance - For the year 2024, the company reported a revenue of 1.299 billion yuan, a year-on-year increase of 21.78%, while the net profit attributable to shareholders was a loss of 77.32 million yuan, compared to a profit of 92.51 million yuan in the previous year [4][5] - The net cash flow from operating activities decreased by 10.10% to 139.04 million yuan [4][5] - In Q1 2025, the company achieved a revenue of 324 million yuan, a year-on-year increase of 13.28%, but the net profit attributable to shareholders decreased by 34.48% to 12.41 million yuan [4][5]

Summary of Key Points Core Viewpoint - The announcement details a share reduction plan by major shareholders of Beijiajie Group Co., Ltd., indicating a need for liquidity and outlining the specifics of the planned share sales [1][2]. Shareholder Information - The shareholders involved in the reduction are employee stock ownership platforms, specifically Nanjing Xiaobei No. 1 and Nanjing Xiaobei No. 2, which hold shares acquired before the company's IPO and through capital reserve increases [2][3]. Reduction Plan Details - Nanjing Xiaobei No. 1 plans to reduce up to 1,250,000 shares, representing no more than 1.2444% of the total share capital, while Nanjing Xiaobei No. 2 intends to reduce up to 750,000 shares, accounting for no more than 0.7466% of the total share capital [2][4]. - The reduction will occur through block trading within three months starting from 15 trading days after the announcement, with a cap of 2% of total shares in any 90-day period [2][5]. Shareholder Background - Nanjing Xiaobei No. 1 holds 6,875,000 shares (6.8443% of total), while Nanjing Xiaobei No. 2 holds 4,125,000 shares (4.1066% of total) [3][4]. - Both shareholders are identified as having a unified action relationship due to their common control by Zhang Wensheng, the actual controller of the company [4][5]. Compliance and Commitments - The reduction plan complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shanghai Stock Exchange rules [6][7]. - Shareholders have made commitments regarding the holding period and conditions under which shares may be sold, ensuring that the reduction does not affect the company's governance structure or ongoing operations [5][6].

重要内容提示： 股东持股的基本情况 2025 年 5 月 28 日，倍加洁集团股份有限公司（以下简称"公司"或"发行 人"）披露《关于股东变更名称、经营范围、主要经营场所暨完成工商变更登记 的公告》（公告编号：2025-031），公司股东扬州竟成企业管理咨询合伙企业（有 限合伙）的名称变更为南京小倍一号企业管理咨询合伙企业（有限合伙）（以下 简称"小倍一号"）；股东扬州和成企业管理咨询合伙企业（有限合伙）的名称变 更为南京小倍二号企业管理咨询合伙企业（有限合伙）（以下简称"小倍二号"）。 上述股东系公司员工持股平台。 截至本公告披露日，公司股东小倍一号、小倍二号分别持有公司股份 6,875,000 股、4,125,000 股，分别占公司总股本的 6.8443%、4.1066%。上述股 份均来源于公司首次公开发行前持有的股份及上市后以资本公积金转增股本方 式取得的股份，均为无限售条件流通股。 证券代码：603059 证券简称：倍加洁 公告编号：2025-032 倍加洁集团股份有限公司 股东大宗交易减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其 ...

证券代码：603059 证券简称：倍加洁 公告编号：2025-033 倍加洁集团股份有限公司 关于控股子公司住所变更并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 倍加洁集团股份有限公司控股子公司善恩康生物科技（苏州）有限公司（以 下简称"善恩康"）因业务经营发展需要，进行住所变更。善恩康的住所由"昆 山市张浦镇三家路 388 号"变更为"江苏省苏州市昆山市张浦镇德望路 261 号 8 层 9 层"。 善恩康现已办理完成工商变更登记手续，并取得了昆山市数据局换发的营业 执照，除住所变更外，善恩康营业执照其他登记事项未发生改变，变更后的登记 信息如下： 法定代表人：张文生 注册资本：8729.2808 万元整 成立日期：2016 年 09 月 29 日 住所：江苏省苏州市昆山市张浦镇德望路 261 号 8 层 9 层 经营范围：从事生物科技领域内的技术咨询、技术转让、技术服务、技术开 发；食品及食品添加剂的研发、生产；其他食品、饮料（固体饮料）、糖果的生 产（按《食品生产许可证》核定项目经营）；家用电器、电 ...

Core Viewpoint - The company Beijiajie (603059.SH) announced a plan for shareholders to reduce their holdings by a total of 1.99% of the company's shares through block trading due to funding needs [1] Summary by Relevant Sections Shareholder Reduction Plan - Shareholders Xiaobei No.1 and Xiaobei No.2 plan to reduce their holdings by up to 1.25 million shares (1.2444% of total share capital) and 750,000 shares (0.7466% of total share capital) respectively [1] Timing and Conditions - The reduction period is set from July 17, 2025, to October 16, 2025 [1] - The two shareholders are part of the company's employee stock ownership plan and have a concerted action relationship with the actual controller Zhang Wensheng [1] Market Uncertainty - The reduction plan may be subject to uncertainties due to market conditions and the company's stock price [1]

倍加洁（603059）公告，公司股东小倍一号计划减持不超过125万股，占公司总股本的1.2444%；小倍 二号计划减持不超过75万股，占公司总股本的0.7466%。减持方式为大宗交易，减持期间为2025年7月 17日至2025年10月16日。减持原因是股东资金需求。本次减持计划不会对公司治理结构及持续经营情况 产生重大影响。 ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative return of over 20% within the next six months [6][18]. Core Views - The company is focusing on expanding its product categories internally while also pursuing external growth through acquisitions. The performance in 2024 is expected to be impacted by fluctuations in the operations of its associate company, Weimeizi, and underperformance from its subsidiary, Shanenkang, leading to impairment provisions for long-term equity investments and goodwill [1][5]. - The company has a significant production capacity for toothbrushes and wet wipes, and it is actively expanding its toothpaste category, with production capacity increasing from 60 million to 120 million units [3]. Financial Performance Summary - In Q1 2025, the company achieved revenue of 320 million yuan, a year-on-year increase of 13.3%, but the net profit attributable to the parent company was 10 million yuan, a decline of 34.5% year-on-year [1]. - For the full year 2024, the company reported revenue of 1.3 billion yuan, up 21.8% year-on-year, but a net loss of 80 million yuan, a significant decline of 183.6% year-on-year [1][10]. - The gross margin for 2024 was 23.9%, an increase of 0.7 percentage points year-on-year, with specific margins for oral care and wet wipes being 22.6% and 23.5%, respectively [2][11]. Product Segment Summary - In 2024, toothbrush revenue was 500 million yuan, an increase of 8.5% year-on-year, with sales volume reaching 420 million units, a rise of 14.7%. The average price per unit decreased by 5.5% to 1.19 yuan [1]. - Wet wipes generated revenue of 390 million yuan, up 15.3% year-on-year, with sales volume of 5.28 billion pieces, an increase of 19.0%, while the average price per unit decreased by 4.0% to 0.07 yuan [1]. Strategic Initiatives - The company is enhancing its support for its subsidiary, Shanenkang, focusing on developing major customer relationships and implementing performance evaluation mechanisms to improve its financial performance [4]. - The company is also prioritizing the development of its own brand products alongside its ODM business, aiming for scale growth in toothpaste, toothbrushes, and orthodontic care products while ensuring reasonable profit margins [3].